valrubicinpembrolizumabnadofaragene firadenovecDurvalumaberdafitinib
…ducted, no agents have received approval, with the exception of valrubicin, largely attributed to factors such as the varied prior BCG exp…
2articles mentioning drugs
3drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: detalimogene voraplasmid ×
detalimogene voraplasmid
This drug is selected. Its supporting articles are shown below.
Articles mentioning detalimogene voraplasmid
2 articles · page 1 of 1nivolumabpembrolizumabdetalimogene voraplasmidDDXC57BL/6 mice
…r model.Results The expression constructs for pembrolizumab and nivolumab demonstrated dose-dependent expression in vitro. The PD-1/PD-L1…